Plasma phosphorylated neurofilament heavy (p-NfH) and light chains (p-NfL) were investigated in SMA, and a rapid decline was found after splicing-modifier therapy was initiated [8]. The gene discussed is NEFH; the disease is proximal spinal muscular atrophy.